In a massive victory for the pro-life movement, a federal judge has blocked the U.S. Food and Drug Administration’s (FDA’s) approval of mifepristone, one of the two drugs used in a chemical abortion. In the ruling, handed down late on Good Friday, April 7, 2023, U.S. District Judge Matthew Kacsmaryk stayed the FDA’s Sept. 28, 2000, approval of mifepristone. The lawsuit against the FDA was filed by attorneys with Alliance Defending Freedom (ADF) on behalf of four medical groups and four doctors, who allege that the FDA violated the law when it originally approved mifepristone. According to ADF, the lawsuit is “the first to challenge federal government officials for their illegal approval of chemical abortions drugs that harm women and girls.”
Now, you may be wondering why it took nearly 23 years (the lawsuit was initially filed in November 2022) for a group to challenge the FDA’s approval of mifepristone. Judge Kacsmaryk addressed that question in the first page of his 67-page ruling. He wrote: “Over twenty years ago, the United States Food and Drug Administration approved chemical abortion … Why did it take two decades for judicial review in federal court?
“Simply put, FDA stonewalled judicial review — until now. Before Plaintiffs filed this case, FDA ignored their petitions for over sixteen years, even though the law requires an agency response within ‘180 days of receipt of the petition.’ … Had FDA responded to the Plaintiffs’ petitions within the 360 total days allotted, this case would have been in federal court decades earlier. Instead, FDA postponed and procrastinate for nearly 6,000 days (emphasis in original).” |